Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Published:2017-06 Issue:10086 Volume:389 Page:2287-2303
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Blauvelt Andrew,de Bruin-Weller Marjolein,Gooderham Melinda,Cather Jennifer C,Weisman Jamie,Pariser David,Simpson Eric L,Papp Kim A,Hong H Chih-Ho,Rubel Diana,Foley Peter,Prens Errol,Griffiths Christopher E M,Etoh Takafumi,Pinto Pedro Herranz,Pujol Ramon M,Szepietowski Jacek C,Ettler Karel,Kemény Lajos,Zhu Xiaoping,Akinlade Bolanle,Hultsch Thomas,Mastey Vera,Gadkari Abhijit,Eckert Laurent,Amin Nikhil,Graham Neil M H,Pirozzi Gianluca,Stahl Neil,Yancopoulos George D,Shumel Brad

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Atopic dermatitis;Weidinger;Lancet,2016

2. Diagnostic features of atopic dermatitis;Hanifin;Acta Dermatovener (Stockholm),1980

3. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis;Eichenfield;J Am Acad Dermatol,2014

4. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study;Silverberg;J Allergy Clin Immunol,2013

5. Addressing treatment challenges in atopic dermatitis with novel topical therapies;Silverberg;J Dermatolog Treat,2016

Cited by 947 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Atopic Dermatitis in Children;Cureus;2024-09-14

2. Dupilumab treatment reduces caregiver-reported skin pain in patients with moderate-to-severe atopic dermatitis aged 6 months to 5 years;Frontiers in Pediatrics;2024-09-04

3. Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2);JAAD International;2024-09

4. Current and Emerging Biologics for Atopic Dermatitis;Immunology and Allergy Clinics of North America;2024-09

5. From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis;Biomolecules;2024-08-28